Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Vifor Fresenius Medical Care Renal Pharma France, 100–101 Terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris La Défense Cedex, France
Veltassa 8.4 g powder for oral suspension.
Veltassa 16.8 g powder for oral suspension.
Veltassa 25.2 g powder for oral suspension.
| Pharmaceutical Form |
|---|
|
Powder for oral suspension. Off white to light brown powder, with occasional white particles. |
Each sachet contains 8.4 g patiromer (as patiromer sorbitex calcium).
Each sachet contains 16.8 g patiromer (as patiromer sorbitex calcium).
Each sachet contains 25.2 g patiromer (as patiromer sorbitex calcium).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Patiromer |
Patiromer is a non-absorbed, cation exchange polymer that contains a calcium-sorbitol complex as a counterion. Patiromer increases faecal potassium excretion through binding of potassium in the lumen of the gastrointestinal tract. |
| List of Excipients |
|---|
|
Xanthan gum |
8.4 g, 16.8 g or 25.2 g of patiromer, as powder in sachets made of five layers: polyethylene, aluminium, polyethylene, polyester and paper.
Pack sizes: boxes of 30, 60 or 90 sachets.
Not all pack sizes may be marketed.
Vifor Fresenius Medical Care Renal Pharma France, 100–101 Terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris La Défense Cedex, France
EU/1/17/1179/001
EU/1/17/1179/002
EU/1/17/1179/003
EU/1/17/1179/004
EU/1/17/1179/005
EU/1/17/1179/006
EU/1/17/1179/007
EU/1/17/1179/008
EU/1/17/1179/009
Date of first authorisation: 19 July 2017
| Drug | Countries | |
|---|---|---|
| VELTASSA | Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
